Sustained virological response after treatment with direct antiviral agents in individuals with HIV and hepatitis C co-infection.

Authors:
Lodi S; Klein M; Rauch A; Epstein R; Wittkop L and 16 more

Journal:
J Int AIDS Soc

Publication Year: 2022

DOI:
10.1002/jia2.26048

PMCID:
PMC9784654

PMID:
36562643

Journal Information

Full Title: J Int AIDS Soc

Abbreviation: J Int AIDS Soc

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Acquired Immunodeficiency Syndrome

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"COMPETING INTERESTS MK reports grants from ViiV Healthcare, Abbvie and Gilead outside this work; and honoraria for advisory boards from ViiV Healthcare and Abbvie. JG has received honoraria for participation as an ad hoc member of Canadian National HIV Advisory Boards to Merck Gilead and ViiV. GT has received grants unrelated to this study and paid to her institution from Gilead Sciences Europe, UCL, ECDC, EU and National funds. MAH reports consultancy fees from Cytel and ProPublica. No other conflict to report."

Evidence found in paper:

"FUNDING This research was supported by the National Institutes of Health grant R37 AI102634 and by the Providence/Boston Center for AIDS Research (P30AI042853)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025